Protection against lethal challenge by Ebola virus-like particles produced in insect cells

Yuliang Sun, Ricardo Carrion, Ling Ye, Zhiyuan Wen, Young Tae Ro, Kathleen Brasky, Anysha E. Ticer, E. Ellen Schwegler, Jean L. Patterson, Richard W. Compans, Chinglai Yang

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Ebola virus-like particles (VLPs) were produced in insect cells using a recombinant baculovirus expression system and their efficacy for protection against Ebola virus infection was investigated. Two immunizations with 50 μg Ebola VLPs (high dose) induced a high level of antibodies against Ebola GP that exhibited strong neutralizing activity against GP-mediated virus infection and conferred complete protection of vaccinated mice against lethal challenge by a high dose of mouse-adapted Ebola virus. In contrast, two immunizations with 10 μg Ebola VLPs (low dose) induced 5-fold lower levels of antibodies against GP and these mice were not protected against lethal Ebola virus challenge, similar to control mice that were immunized with 50 μg SIV Gag VLPs. However, the antibody responses against GP were boosted significantly after a third immunization with 10 μg Ebola VLPs to similar levels as those induced by two immunizations with 50 μg Ebola VLPs, and vaccinated mice were also effectively protected against lethal Ebola virus challenge. Furthermore, serum viremia levels in protected mice were either below the level of detection or significantly lower compared to the viremia levels in control mice. These results show that effective protection can be achieved by immunization with Ebola VLPs produced in insect cells, which give high production yields, and lend further support to their development as an effective vaccine strategy against Ebola virus.

Original languageEnglish (US)
Pages (from-to)12-21
Number of pages10
JournalVirology
Volume383
Issue number1
DOIs
StatePublished - Jan 5 2009
Externally publishedYes

Fingerprint

Ebolavirus
Virion
Insects
Immunization
Viremia
Ebola Hemorrhagic Fever
Antibodies
Baculoviridae
Virus Diseases
Antibody Formation
Vaccines

Keywords

  • Antibody
  • Ebola virus
  • Lethal challenge
  • Vaccine
  • Virus like particle

ASJC Scopus subject areas

  • Virology

Cite this

Sun, Y., Carrion, R., Ye, L., Wen, Z., Ro, Y. T., Brasky, K., ... Yang, C. (2009). Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology, 383(1), 12-21. https://doi.org/10.1016/j.virol.2008.09.020

Protection against lethal challenge by Ebola virus-like particles produced in insect cells. / Sun, Yuliang; Carrion, Ricardo; Ye, Ling; Wen, Zhiyuan; Ro, Young Tae; Brasky, Kathleen; Ticer, Anysha E.; Schwegler, E. Ellen; Patterson, Jean L.; Compans, Richard W.; Yang, Chinglai.

In: Virology, Vol. 383, No. 1, 05.01.2009, p. 12-21.

Research output: Contribution to journalArticle

Sun, Y, Carrion, R, Ye, L, Wen, Z, Ro, YT, Brasky, K, Ticer, AE, Schwegler, EE, Patterson, JL, Compans, RW & Yang, C 2009, 'Protection against lethal challenge by Ebola virus-like particles produced in insect cells', Virology, vol. 383, no. 1, pp. 12-21. https://doi.org/10.1016/j.virol.2008.09.020
Sun, Yuliang ; Carrion, Ricardo ; Ye, Ling ; Wen, Zhiyuan ; Ro, Young Tae ; Brasky, Kathleen ; Ticer, Anysha E. ; Schwegler, E. Ellen ; Patterson, Jean L. ; Compans, Richard W. ; Yang, Chinglai. / Protection against lethal challenge by Ebola virus-like particles produced in insect cells. In: Virology. 2009 ; Vol. 383, No. 1. pp. 12-21.
@article{cfc1d08fd57645d6bb9d23e7f8d35639,
title = "Protection against lethal challenge by Ebola virus-like particles produced in insect cells",
abstract = "Ebola virus-like particles (VLPs) were produced in insect cells using a recombinant baculovirus expression system and their efficacy for protection against Ebola virus infection was investigated. Two immunizations with 50 μg Ebola VLPs (high dose) induced a high level of antibodies against Ebola GP that exhibited strong neutralizing activity against GP-mediated virus infection and conferred complete protection of vaccinated mice against lethal challenge by a high dose of mouse-adapted Ebola virus. In contrast, two immunizations with 10 μg Ebola VLPs (low dose) induced 5-fold lower levels of antibodies against GP and these mice were not protected against lethal Ebola virus challenge, similar to control mice that were immunized with 50 μg SIV Gag VLPs. However, the antibody responses against GP were boosted significantly after a third immunization with 10 μg Ebola VLPs to similar levels as those induced by two immunizations with 50 μg Ebola VLPs, and vaccinated mice were also effectively protected against lethal Ebola virus challenge. Furthermore, serum viremia levels in protected mice were either below the level of detection or significantly lower compared to the viremia levels in control mice. These results show that effective protection can be achieved by immunization with Ebola VLPs produced in insect cells, which give high production yields, and lend further support to their development as an effective vaccine strategy against Ebola virus.",
keywords = "Antibody, Ebola virus, Lethal challenge, Vaccine, Virus like particle",
author = "Yuliang Sun and Ricardo Carrion and Ling Ye and Zhiyuan Wen and Ro, {Young Tae} and Kathleen Brasky and Ticer, {Anysha E.} and Schwegler, {E. Ellen} and Patterson, {Jean L.} and Compans, {Richard W.} and Chinglai Yang",
year = "2009",
month = "1",
day = "5",
doi = "10.1016/j.virol.2008.09.020",
language = "English (US)",
volume = "383",
pages = "12--21",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Protection against lethal challenge by Ebola virus-like particles produced in insect cells

AU - Sun, Yuliang

AU - Carrion, Ricardo

AU - Ye, Ling

AU - Wen, Zhiyuan

AU - Ro, Young Tae

AU - Brasky, Kathleen

AU - Ticer, Anysha E.

AU - Schwegler, E. Ellen

AU - Patterson, Jean L.

AU - Compans, Richard W.

AU - Yang, Chinglai

PY - 2009/1/5

Y1 - 2009/1/5

N2 - Ebola virus-like particles (VLPs) were produced in insect cells using a recombinant baculovirus expression system and their efficacy for protection against Ebola virus infection was investigated. Two immunizations with 50 μg Ebola VLPs (high dose) induced a high level of antibodies against Ebola GP that exhibited strong neutralizing activity against GP-mediated virus infection and conferred complete protection of vaccinated mice against lethal challenge by a high dose of mouse-adapted Ebola virus. In contrast, two immunizations with 10 μg Ebola VLPs (low dose) induced 5-fold lower levels of antibodies against GP and these mice were not protected against lethal Ebola virus challenge, similar to control mice that were immunized with 50 μg SIV Gag VLPs. However, the antibody responses against GP were boosted significantly after a third immunization with 10 μg Ebola VLPs to similar levels as those induced by two immunizations with 50 μg Ebola VLPs, and vaccinated mice were also effectively protected against lethal Ebola virus challenge. Furthermore, serum viremia levels in protected mice were either below the level of detection or significantly lower compared to the viremia levels in control mice. These results show that effective protection can be achieved by immunization with Ebola VLPs produced in insect cells, which give high production yields, and lend further support to their development as an effective vaccine strategy against Ebola virus.

AB - Ebola virus-like particles (VLPs) were produced in insect cells using a recombinant baculovirus expression system and their efficacy for protection against Ebola virus infection was investigated. Two immunizations with 50 μg Ebola VLPs (high dose) induced a high level of antibodies against Ebola GP that exhibited strong neutralizing activity against GP-mediated virus infection and conferred complete protection of vaccinated mice against lethal challenge by a high dose of mouse-adapted Ebola virus. In contrast, two immunizations with 10 μg Ebola VLPs (low dose) induced 5-fold lower levels of antibodies against GP and these mice were not protected against lethal Ebola virus challenge, similar to control mice that were immunized with 50 μg SIV Gag VLPs. However, the antibody responses against GP were boosted significantly after a third immunization with 10 μg Ebola VLPs to similar levels as those induced by two immunizations with 50 μg Ebola VLPs, and vaccinated mice were also effectively protected against lethal Ebola virus challenge. Furthermore, serum viremia levels in protected mice were either below the level of detection or significantly lower compared to the viremia levels in control mice. These results show that effective protection can be achieved by immunization with Ebola VLPs produced in insect cells, which give high production yields, and lend further support to their development as an effective vaccine strategy against Ebola virus.

KW - Antibody

KW - Ebola virus

KW - Lethal challenge

KW - Vaccine

KW - Virus like particle

UR - http://www.scopus.com/inward/record.url?scp=57049090480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049090480&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2008.09.020

DO - 10.1016/j.virol.2008.09.020

M3 - Article

VL - 383

SP - 12

EP - 21

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -